Kevin Clayton Awarded F31 NRSA from the National Institute on Aging

Kevin Clayton has been awarded an F31 Ruth L. Kirschstein National Research Service Award from the National Institute on Aging. The title of his Ph.D. thesis research is “TREM12-TYROBP coupling modulation for the reduction of Alzheimer’s-mediated neuroinflammation: a novel pharmacologic therapy.” Kevin, a Program in Biomolecular Pharmacology Ph.D. graduate student, is conducting his thesis research in the Laboratory of Molecular NeuroTherapeutics under the mentorship of Tsuneya Ikezu, M.D./Ph.D., Professor of Pharmacology and Neurology.

Congratulations, Kevin!